Thermo Fisher Scientific Gibco CTS OpTmizer Pro Serum Free Media (SFM)

Wednesday, 10 February, 2021 | Supplied by: Thermo Fisher Scientific


Thermo Fisher Scientific has developed a medium for the development and expansion of human T lymphocytes (T cells) for cell therapy developers using allogeneic workflows. The Gibco CTS OpTmizer Pro Serum Free Media (SFM) is a media solution that targets the metabolism of healthy donor cells, making it suitable for use in the production of allogeneic, off-the-shelf cell therapies.

In contrast to autologous cell therapies, which are produced using a patient’s own cells, allogeneic cell therapies are derived from healthy donor tissue, potentially enabling more scalable cell therapy manufacturing. The SFM enhances donor T cell proliferation, maintains central memory T cells further into expansion and delays effector differentiation of healthy donor T cells, resulting in fast production of central memory cells.

The product packaging is suitable for closed systems and is manufactured in conformity with current Good Manufacturing Practice (cGMP) standards. The serum-free media is ready to use and compatible with automated and long workflows, providing a consistent formulation designed to maintain cell quality and increase the efficacy of cell-based therapies.

Online: thermofisher.com
Phone: 1300 735 292
Related Products

AMSL Scientific CompactDry Total Count Rapid (TCR)

Next-day results are available with CompactDry TCR for total viable counts — an...

The Native Antigen Company monkeypox antigens

The Native Antigen Company has moved to develop a series of monkeypox antigens to support...

Zymo Research DNA/RNA Shield inactivating transport medium

Zymo Research, in collaboration with the Institute of Virology at University Medical Center...


  • All content Copyright © 2022 Westwick-Farrow Pty Ltd